MARKET

IRIX

IRIX

IRIDEX
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.49
+0.28
+3.88%
Closed 16:00 05/14 EDT
OPEN
7.18
PREV CLOSE
7.21
HIGH
7.80
LOW
6.96
VOLUME
110.33K
TURNOVER
--
52 WEEK HIGH
9.71
52 WEEK LOW
1.460
MARKET CAP
117.04M
P/E (TTM)
-16.3573
1D
5D
1M
3M
1Y
5Y
Analysts Offer Insights on Healthcare Companies: Iridex (IRIX), Global Blood Therapeutics (GBT) and Moleculin Biotech (MBRX)
SmarterAnalyst · 3d ago
--Roth Capital Adjusts Price Target on IRIDEX to $11 From $9, Maintains Buy Rating
MT Newswires · 4d ago
8-K: IRIDEX CORP
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [[Image Removed]] FORM 8K CURRENT REPORT [[Image Removed]] PURSUANT TO SECTION 13 OR...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 4d ago
Recap: Iridex Q1 Earnings
Shares of Iridex (NASDAQ:IRIX) were flat after the company reported Q1 results. Quarterly Results Earnings per share decreased 16.67% year over year to ($0.14), which were in line with the estimate of ($0.14).
Benzinga · 4d ago
IRIDEX EPS in-line, beats on revenue
IRIDEX (IRIX): Q1 GAAP EPS of -$0.14 in-line.Revenue of $11.96M (+32.6% Y/Y) beats by $2.06M.Press Release
Seekingalpha · 4d ago
Iridex Announces First Quarter 2021 Financial Results
MOUNTAIN VIEW, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 3, 2021. First Quarter Highlights Closed strategic collaboration with Topcon Corporation netting $1...
GlobeNewswire · 4d ago
IRIDEX Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 11, 2021 / IRIDEX Corp. (NASDAQ:IRIX) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 11, 2021 at 5:00 PM Eastern Time.
ACCESSWIRE · 4d ago
IRIDEX Net Loss Widens in Q1 While Sales Advance
MT Newswires · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IRIX. Analyze the recent business situations of IRIDEX through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IRIX stock price target is 10.50 with a high estimate of 11.00 and a low estimate of 10.00.
EPS
Institutional Holdings
Institutions: 44
Institutional Holdings: 5.72M
% Owned: 36.58%
Shares Outstanding: 15.63M
TypeInstitutionsShares
Increased
4
78.68K
New
10
328.23K
Decreased
7
688.68K
Sold Out
3
34.15K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.10%
Healthcare Equipment & Supplies
+1.17%
Key Executives
Chairman/Independent Director
Robert Gunst
President/Chief Executive Officer/Director
David Bruce
Chief Financial Officer
Fuad Ahmad
Chief Operating Officer
Patrick Mercer
Independent Director
Doris Engibous
Independent Director
Robert Grove
Independent Director
Kenneth Ludlum
Independent Director
Scott Shuda
No Data
About IRIX
IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company's ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.

Webull offers kinds of IRIDEX Corporation stock information, including NASDAQ:IRIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IRIX stock methods without spending real money on the virtual paper trading platform.